Latest Period
Q1 2026
Security Snapshot
BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA) Institutional Ownership
CUSIP: 09060U606
13F Institutional Holders and Ownership History from Q2 2024 to Q1 2026
Institutions Reporting
18
Shares (Excl. Options)
686,585
Price
$1.21
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- BCDA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 686,585
- Total 13F value
- $831,135
- Portfolio coverage rank
- 0%
- Share change
- -18,187
- Value change
- -$26,108
- Number of holders
- 18
- Shares outstanding
- 11,165,912
- SEC-reported price per share
- $0.92
- Insider filing price
- $0.92
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BCDA - BioCardia, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 09060U606.
- 18 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 20 to 18 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $812,287 to $831,135.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 18 institutions filings for Q1 2026.
Security key
09060U606
Latest holder period
Q1 2026
13F holders
18
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
BCDA full holder history
BioCardia, Inc. SEC filings
BioCardia, Inc. company facts
BioCardia, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09060U606:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
BCDA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Lincoln Alternative Strategies LLC | 7.5% | $1,560,000 | 800,000 | Lincoln Alternative Strategies LLC | 19 Sep 2025 | |||
| SATTERFIELD THOMAS A JR | 9.9% | +21% | $1,356,010 | +$467,153 | 592,144 | +53% | Thomas A. Satterfield, Jr. | 30 Jun 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $1,086,499 | 557,179 | Mitchell P. Kopin | 18 Sep 2025 | |||
| Blank Andrew Scott | 5.5% | $848,672 | 278,253 | Blank Andrew Scott | 23 Apr 2025 |
As of 31 Mar 2026, 18 institutional investors reported holding 686,585 shares of BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA). This represents 6.1% of the company’s total 11,165,912 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Latest
Q1 2026
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 686,585 | $831,135 | -$26,108 | $1.21 | 18 |
| 2025 Q4 | 649,615 | $812,287 | +$277,290 | $1.25 | 20 |
| 2025 Q3 | 427,093 | $551,879 | +$144,113 | $1.29 | 18 |
| 2025 Q2 | 304,344 | $593,207 | +$114,077 | $1.95 | 16 |
| 2025 Q1 | 245,413 | $623,766 | +$308,212 | $2.54 | 12 |
| 2024 Q4 | 124,849 | $272,169 | +$50,907 | $2.18 | 13 |
| 2024 Q3 | 101,482 | $316,622 | +$81,316 | $3.12 | 9 |
| 2024 Q2 | 75,419 | $223,995 | +$223,995 | $2.97 | 8 |